Oxygen‐induced marrow red cell hypoplasia leading to transfusion in sickle painful crisis
The benefit of oxygen (O2) therapy in non‐hypoxic sickle cell patients in painful crisis is uncertain. We report a case of a non‐hypoxic sickle cell patient in painful crisis who developed marrow red cell hypoplasia requiring transfusion support after O2 therapy. The uncertain benefits of O2 use in...
Gespeichert in:
| Veröffentlicht in: | American journal of hematology 1988-01, Vol.27 (1), p.67-68 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 68 |
|---|---|
| container_issue | 1 |
| container_start_page | 67 |
| container_title | American journal of hematology |
| container_volume | 27 |
| creator | Lane, Philip K. Embury, Stephen H. Toy, Pearl T. C. Y. |
| description | The benefit of oxygen (O2) therapy in non‐hypoxic sickle cell patients in painful crisis is uncertain. We report a case of a non‐hypoxic sickle cell patient in painful crisis who developed marrow red cell hypoplasia requiring transfusion support after O2 therapy. The uncertain benefits of O2 use in such cases must be weighed against the serious and underrecognized risks of transfusion. In patients who develop O2‐induced marrow red cell hypoplasia, cessation of O2 therapy may reverse the anemia and obviate the need for transfusion. |
| doi_str_mv | 10.1002/ajh.2830270117 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ajh_2830270117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AJH2830270117</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3697-86ee22fb0a65d8bfdf8fbad01717120909f0dad48af44a1f48c1ad99824973f63</originalsourceid><addsrcrecordid>eNqFkMtOAjEUhhujQUS37ky6cAuedoaZdkmIioaEja5cTDq9QLHMTFoIzs5H8Bl9Eksg6M6cxTnJ_53bj9A1gQEBoHdiuRhQlgDNgZD8BHUJ8KzPsiE9RV1IMhJr4OfoIoQlRCRl0EGdhFBGIOuit9lHO9fV9-eXrdRGaoVXwvt6i30spXYOL9qmbpwIVmCnhbLVHK9rvPaiCmYTbF1hW-Fg5bvTuBG2MhuHpbfBhkt0ZoQL-uqQe-j14f5lPOlPZ49P49G0L5OM5_E-rSk1JYhsqFhplGGmFApIHoMCB25ACZUyYdJUEJMySYTinNGU54nJkh4a7OdKX4fgtSkab-MbbUGg2JlURJOKX5Niw82-odmUK62O-MGVqN8edBGkcCb-Km04YnmaJ0m-w_ge21qn23-WFqPnyZ8TfgAB6oIc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Oxygen‐induced marrow red cell hypoplasia leading to transfusion in sickle painful crisis</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><creator>Lane, Philip K. ; Embury, Stephen H. ; Toy, Pearl T. C. Y.</creator><creatorcontrib>Lane, Philip K. ; Embury, Stephen H. ; Toy, Pearl T. C. Y.</creatorcontrib><description>The benefit of oxygen (O2) therapy in non‐hypoxic sickle cell patients in painful crisis is uncertain. We report a case of a non‐hypoxic sickle cell patient in painful crisis who developed marrow red cell hypoplasia requiring transfusion support after O2 therapy. The uncertain benefits of O2 use in such cases must be weighed against the serious and underrecognized risks of transfusion. In patients who develop O2‐induced marrow red cell hypoplasia, cessation of O2 therapy may reverse the anemia and obviate the need for transfusion.</description><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.2830270117</identifier><identifier>PMID: 3128106</identifier><identifier>CODEN: AJHEDD</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Anemia, Sickle Cell - complications ; Anemia, Sickle Cell - therapy ; Anemias. Hemoglobinopathies ; Biological and medical sciences ; blood grouping and crossmatching ; blood groups ; Blood Transfusion ; Bone Marrow - drug effects ; Bone Marrow - pathology ; Diseases of red blood cells ; Female ; Hematologic and hematopoietic diseases ; Humans ; Medical sciences ; oxygen inhalation therapy ; Oxygen Inhalation Therapy - adverse effects ; Pain Management ; pure red cell aplasia ; Red-Cell Aplasia, Pure - chemically induced ; Red-Cell Aplasia, Pure - therapy ; Sickle cell anemia</subject><ispartof>American journal of hematology, 1988-01, Vol.27 (1), p.67-68</ispartof><rights>Copyright © 1988 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3697-86ee22fb0a65d8bfdf8fbad01717120909f0dad48af44a1f48c1ad99824973f63</citedby><cites>FETCH-LOGICAL-c3697-86ee22fb0a65d8bfdf8fbad01717120909f0dad48af44a1f48c1ad99824973f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.2830270117$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.2830270117$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,4024,27923,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7473376$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3128106$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lane, Philip K.</creatorcontrib><creatorcontrib>Embury, Stephen H.</creatorcontrib><creatorcontrib>Toy, Pearl T. C. Y.</creatorcontrib><title>Oxygen‐induced marrow red cell hypoplasia leading to transfusion in sickle painful crisis</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><description>The benefit of oxygen (O2) therapy in non‐hypoxic sickle cell patients in painful crisis is uncertain. We report a case of a non‐hypoxic sickle cell patient in painful crisis who developed marrow red cell hypoplasia requiring transfusion support after O2 therapy. The uncertain benefits of O2 use in such cases must be weighed against the serious and underrecognized risks of transfusion. In patients who develop O2‐induced marrow red cell hypoplasia, cessation of O2 therapy may reverse the anemia and obviate the need for transfusion.</description><subject>Adult</subject><subject>Anemia, Sickle Cell - complications</subject><subject>Anemia, Sickle Cell - therapy</subject><subject>Anemias. Hemoglobinopathies</subject><subject>Biological and medical sciences</subject><subject>blood grouping and crossmatching</subject><subject>blood groups</subject><subject>Blood Transfusion</subject><subject>Bone Marrow - drug effects</subject><subject>Bone Marrow - pathology</subject><subject>Diseases of red blood cells</subject><subject>Female</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>oxygen inhalation therapy</subject><subject>Oxygen Inhalation Therapy - adverse effects</subject><subject>Pain Management</subject><subject>pure red cell aplasia</subject><subject>Red-Cell Aplasia, Pure - chemically induced</subject><subject>Red-Cell Aplasia, Pure - therapy</subject><subject>Sickle cell anemia</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOAjEUhhujQUS37ky6cAuedoaZdkmIioaEja5cTDq9QLHMTFoIzs5H8Bl9Eksg6M6cxTnJ_53bj9A1gQEBoHdiuRhQlgDNgZD8BHUJ8KzPsiE9RV1IMhJr4OfoIoQlRCRl0EGdhFBGIOuit9lHO9fV9-eXrdRGaoVXwvt6i30spXYOL9qmbpwIVmCnhbLVHK9rvPaiCmYTbF1hW-Fg5bvTuBG2MhuHpbfBhkt0ZoQL-uqQe-j14f5lPOlPZ49P49G0L5OM5_E-rSk1JYhsqFhplGGmFApIHoMCB25ACZUyYdJUEJMySYTinNGU54nJkh4a7OdKX4fgtSkab-MbbUGg2JlURJOKX5Niw82-odmUK62O-MGVqN8edBGkcCb-Km04YnmaJ0m-w_ge21qn23-WFqPnyZ8TfgAB6oIc</recordid><startdate>198801</startdate><enddate>198801</enddate><creator>Lane, Philip K.</creator><creator>Embury, Stephen H.</creator><creator>Toy, Pearl T. C. Y.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>198801</creationdate><title>Oxygen‐induced marrow red cell hypoplasia leading to transfusion in sickle painful crisis</title><author>Lane, Philip K. ; Embury, Stephen H. ; Toy, Pearl T. C. Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3697-86ee22fb0a65d8bfdf8fbad01717120909f0dad48af44a1f48c1ad99824973f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Anemia, Sickle Cell - complications</topic><topic>Anemia, Sickle Cell - therapy</topic><topic>Anemias. Hemoglobinopathies</topic><topic>Biological and medical sciences</topic><topic>blood grouping and crossmatching</topic><topic>blood groups</topic><topic>Blood Transfusion</topic><topic>Bone Marrow - drug effects</topic><topic>Bone Marrow - pathology</topic><topic>Diseases of red blood cells</topic><topic>Female</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>oxygen inhalation therapy</topic><topic>Oxygen Inhalation Therapy - adverse effects</topic><topic>Pain Management</topic><topic>pure red cell aplasia</topic><topic>Red-Cell Aplasia, Pure - chemically induced</topic><topic>Red-Cell Aplasia, Pure - therapy</topic><topic>Sickle cell anemia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lane, Philip K.</creatorcontrib><creatorcontrib>Embury, Stephen H.</creatorcontrib><creatorcontrib>Toy, Pearl T. C. Y.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lane, Philip K.</au><au>Embury, Stephen H.</au><au>Toy, Pearl T. C. Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oxygen‐induced marrow red cell hypoplasia leading to transfusion in sickle painful crisis</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>1988-01</date><risdate>1988</risdate><volume>27</volume><issue>1</issue><spage>67</spage><epage>68</epage><pages>67-68</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><coden>AJHEDD</coden><abstract>The benefit of oxygen (O2) therapy in non‐hypoxic sickle cell patients in painful crisis is uncertain. We report a case of a non‐hypoxic sickle cell patient in painful crisis who developed marrow red cell hypoplasia requiring transfusion support after O2 therapy. The uncertain benefits of O2 use in such cases must be weighed against the serious and underrecognized risks of transfusion. In patients who develop O2‐induced marrow red cell hypoplasia, cessation of O2 therapy may reverse the anemia and obviate the need for transfusion.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>3128106</pmid><doi>10.1002/ajh.2830270117</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0361-8609 |
| ispartof | American journal of hematology, 1988-01, Vol.27 (1), p.67-68 |
| issn | 0361-8609 1096-8652 |
| language | eng |
| recordid | cdi_crossref_primary_10_1002_ajh_2830270117 |
| source | MEDLINE; Wiley Online Library Journals |
| subjects | Adult Anemia, Sickle Cell - complications Anemia, Sickle Cell - therapy Anemias. Hemoglobinopathies Biological and medical sciences blood grouping and crossmatching blood groups Blood Transfusion Bone Marrow - drug effects Bone Marrow - pathology Diseases of red blood cells Female Hematologic and hematopoietic diseases Humans Medical sciences oxygen inhalation therapy Oxygen Inhalation Therapy - adverse effects Pain Management pure red cell aplasia Red-Cell Aplasia, Pure - chemically induced Red-Cell Aplasia, Pure - therapy Sickle cell anemia |
| title | Oxygen‐induced marrow red cell hypoplasia leading to transfusion in sickle painful crisis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T14%3A06%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oxygen%E2%80%90induced%20marrow%20red%20cell%20hypoplasia%20leading%20to%20transfusion%20in%20sickle%20painful%20crisis&rft.jtitle=American%20journal%20of%20hematology&rft.au=Lane,%20Philip%20K.&rft.date=1988-01&rft.volume=27&rft.issue=1&rft.spage=67&rft.epage=68&rft.pages=67-68&rft.issn=0361-8609&rft.eissn=1096-8652&rft.coden=AJHEDD&rft_id=info:doi/10.1002/ajh.2830270117&rft_dat=%3Cwiley_cross%3EAJH2830270117%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3128106&rfr_iscdi=true |